(Q37991272)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396215%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

The ongoing pursuit of a prophylactic HSV vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396215%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396215%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Jonathan Sen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396215%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

7 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396215%20AND%20SRC:MED&resulttype=core&format=json

Reviews in Medical Virology

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396215%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396215%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396215%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

285-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396215%20AND%20SRC:MED&resulttype=core&format=json

Relapsing herpes simplex encephalitis: pathological confirmation of viral reactivation

25 January 2020

cites work

1 reference

Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis

21 January 2018

1 reference

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

21 January 2018

1 reference

Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women

21 January 2018

1 reference

Herpes simplex virus type 2 and heterosexual spread of human immunodeficiency virus infection in developing countries: hypotheses and research priorities

21 January 2018

1 reference

Once-daily valacyclovir to reduce the risk of transmission of genital herpes

21 January 2018

1 reference

American College Health Association annual Pap test and sexually transmitted infection survey: 2006.

21 January 2018

1 reference

Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992-2006.

21 January 2018

1 reference

Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review

21 January 2018

1 reference

Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada

21 January 2018

1 reference

Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey

21 January 2018

1 reference

Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection.

21 January 2018

1 reference

Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994.

21 January 2018

1 reference

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection

21 January 2018

1 reference

Neonatal herpes simplex infection

21 January 2018

1 reference

Neonatal herpes simplex virus infections: where are we now?

21 January 2018

1 reference

Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections

21 January 2018

1 reference

Antiviral agents for treatment of herpes simplex virus infection in neonates

21 January 2018

1 reference

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.

21 January 2018

1 reference

The impact of active herpes simplex virus infection on human immunodeficiency virus load

21 January 2018

1 reference

Structural features of the scaffold interaction domain at the N terminus of the major capsid protein (VP5) of herpes simplex virus type 1.

21 January 2018

1 reference

Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathway

21 January 2018

1 reference

Understanding HSV-1 entry glycoproteins.

21 January 2018

1 reference

Herpes simplex virus: receptors and ligands for cell entry

21 January 2018

1 reference

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

21 January 2018

1 reference

The multipartite system that mediates entry of herpes simplex virus into the cell

21 January 2018

1 reference

Bimolecular complementation defines functional regions of Herpes simplex virus gB that are involved with gH/gL as a necessary step leading to cell fusion

21 January 2018

1 reference

Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle

21 January 2018

1 reference

Topics in herpesvirus genomics and evolution

21 January 2018

1 reference

HSV trafficking and development of gene therapy vectors with applications in the nervous system

21 January 2018

1 reference

Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia

21 January 2018

1 reference

ICP0, a regulator of herpes simplex virus during lytic and latent infection

21 January 2018

1 reference

Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus

21 January 2018

1 reference

Immune control of herpes simplex virus during latency

21 January 2018

1 reference

Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes

21 January 2018

1 reference

Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development

21 January 2018

1 reference

Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.

21 January 2018

1 reference

CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells.

21 January 2018

1 reference

Dendritic cells prime natural killer cells by trans-presenting interleukin 15

21 January 2018

1 reference

Immune control of HSV-1 latency

21 January 2018

1 reference

Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons

21 January 2018

1 reference

Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice

21 January 2018

1 reference

Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in mice

21 January 2018

1 reference

Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes

21 January 2018

1 reference

CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help

21 January 2018

1 reference

Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection

21 January 2018

1 reference

Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs.

21 January 2018

1 reference

Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs

21 January 2018

1 reference

Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK.

21 January 2018

1 reference

Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease

21 January 2018

1 reference

Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice

21 January 2018

1 reference

Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1.

21 January 2018

1 reference

Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs

21 January 2018

1 reference

Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein

21 January 2018

1 reference

Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs

21 January 2018

1 reference

A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine

21 January 2018

1 reference

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

21 January 2018

1 reference

DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2.

21 January 2018

1 reference

Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27.

21 January 2018

1 reference

Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs

21 January 2018

1 reference

The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice

21 January 2018

1 reference

DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo

21 January 2018

1 reference

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins

21 January 2018

1 reference

Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract

21 January 2018

1 reference

Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone

21 January 2018

1 reference

Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system

21 January 2018

1 reference

Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

21 January 2018

1 reference

A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection

21 January 2018

1 reference

Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection

21 January 2018

1 reference

Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infection

21 January 2018

1 reference

Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus

21 January 2018

1 reference

Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens

21 January 2018

1 reference

Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response.

21 January 2018

1 reference

Alphavirus vectors and vaccination

21 January 2018

1 reference

Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D.

21 January 2018

1 reference

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.

21 January 2018

1 reference

Follow-up report on 50 subjects vaccinated against herpes genitalis with Skinner vaccine

21 January 2018

1 reference

Prospects for control of herpes simplex virus disease through immunization.

21 January 2018

1 reference

Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus

21 January 2018

1 reference

Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs

21 January 2018

1 reference

DNA Sequence Analysis of the Type-Common Glycoprotein-D Genes of Herpes Simplex Virus Types 1 and 2

21 January 2018

1 reference

Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infection

21 January 2018

1 reference

Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs

21 January 2018

1 reference

Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial

21 January 2018

1 reference

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

21 January 2018

1 reference

A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]

21 January 2018

1 reference

Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine

21 January 2018

1 reference

Efficacy results of a trial of a herpes simplex vaccine

21 January 2018

1 reference

A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge

21 January 2018

1 reference

A mucosal vaccination approach for herpes simplex virus type 2.

21 January 2018

1 reference

Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines

21 January 2018

1 reference

Lipopeptide vaccines--yesterday, today, and tomorrow

21 January 2018

1 reference

A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine

21 January 2018

1 reference

Virus-like particles in vaccine development.

21 January 2018

1 reference

Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use.

21 January 2018

1 reference

Liposomal vaccines--targeting the delivery of antigen

21 January 2018

1 reference

Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).

21 January 2018

1 reference

Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein D plasmid constructs

21 January 2018

1 reference

Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected Subjects

21 January 2018

1 reference

A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy

21 January 2018

1 reference

Efficacy of a nucleic acid free herpetic subunit vaccine.

21 January 2018

1 reference

Placebo-controlled study with subunit herpes simplex virus vaccine in subjects suffering from frequent herpetic recurrences

21 January 2018

1 reference

Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes

21 January 2018

1 reference

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

21 January 2018

1 reference

Safety and Immunogenicity of Glycoprotein D--Adjuvant Genital Herpes Vaccine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.1709

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396215%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference